The major deal between Canada’s two main telecom companies, Rogers and Shaw, made progress on Friday, helping the TSX close higher in a broad increase across sectors. Gains were capped on concerns over “soft landing” challenges for the economy, however.

Wall Street’s main indexes also closed higher, seeing the NASDAQ and S&P 500 score a fourth straight week of gains. Bets of another super-sized interest rate hike seem to be cooling on evidence that inflation could be easing.

Today in the Markets

TSX 20,179.81 +187.93 TSX
TSXV 680.51 +7.49 TSXV
CSE 287.39 -0.23 TSXV
DJIA 33,761.05 +424.38 DJIA
NASDAQ 13,047.19 +267.27 NASDAQ
S&P 500 4,280.15 +72.88 S&P 500

The Canadian dollar traded for 78.25 cents US compared to 78.36 cents US on Thursday.

US crude futures traded 2.69 per cent lower at $91.80 a barrel, while the Brent contract lost 1.75 per cent to $97.86 a barrel.

The price of gold was up US$12.66 to US$1,801.81.

In world markets, the Nikkei was up 727.65 points to 28,546.98, the Hang Seng was up 93.19 points to 20,175.62, the FTSE was up 37.53 points to 7,626.27, and the DAX was up 101.34 points to 13,795.85.


Get @ the Bell delivered to your email inbox every day!

Sign Up Here


DISCLAIMER: By viewing any material on or distributed by The Market Herald Publishing Ltd. and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.

Any holdings, theories, speculation or trades appearing anywhere on The Market Herald network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to The Market Herald or employees of The Market Herald may from time to time have positions in the stocks or other entities mentioned anywhere on The Market Herald Network of websites. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. The Market Herald and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by The Market Herald and other Information Providers on an “as is” basis, and The Market Herald and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall The Market Herald and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.
More From The Market Online
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
Q Precious & Battery Metals drill core sample

A critical minerals stock to future-proof your portfolio

This critical minerals stock offers investors numerous projects poised to capture significant upside as ESG principles become table stakes.